A Novel Treatment Option for Hepatocellular Carcinoma

A Novel Treatment Option for Hepatocellular Carcinoma

0 0 circa un anno fa
In this episode of The OncoZine Brief, Peter Hofland, Ph.D and Sonia Portillo talk with Gisela Schwab, MD, President, Product Development and Medical Affairs and Chief Medical Officer at Exelixis.

Following early work in model genetic systems, Exelixis, a genomics-based drug discovery company located in South San Francisco, CA, established a broad drug discovery and development platform that has served as the foundation for the company’s continued efforts to bring new cancer therapies to ... Maggiori informazioni

Seguici su Facebook

iAB member
Copyright 2019 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY
Aiuto